Supply Chain
Attitudes toward healthcare financing have been fairly conservative ever since the general economy collapsed with the stock market in 2008.
Hospitals and health systems try their best to anticipate and meet the demand for specific drugs. But drug shortages - whether due to outbreaks of specific illnesses or unanticipated supply bottlenecks - are a fact of life in the medical world.
The U.S. Department of Health and Human Services will sponsor the advanced development of a next-generation portable ventilator to help fill the need for portable, low-cost, user-friendly and flexible ventilators in a pandemic or other public health emergency.
New research by the Centers for Disease Control and Prevention and Premier, Inc., concludes that the inappropriate use of antibiotics in U.S. hospitals could result in an estimated $163 million in excessive costs.
The 340B program is critical for hospitals and other providers that serve some of our country's poorest and most vulnerable patients. When providers monitor compliance and track 340B drugs properly, the program can fulfill its intended purpose.
The drought in California has everyone concerned that food prices will skyrocket, but so far, the impact of the severe weather has been low for most hospitals, and where felt, strategies have been implemented to minimize the damage.
Software is making supply chain automation a long hoped for reality and the biggest reason your hospital is likely to get on board is money.
Healthcare systems have used value analysis since the 1990s, but the process is gaining more prominence amid the uncertainty created by healthcare reform and other changes in the way hospitals are reimbursed.
Although a May 2014 U.S. District Court ruling vacated HRSA's 340B orphan drug regulation, the agency has issued an interpretive rule affirming its policy on the orphan drug exemption. The pharma industry is up in arms, but what does it all mean?
For many larger healthcare organizations, group purchasing has yielded significant savings. Physician practices are also mulling whether or not they can achieve savings through aggregated procurement.